Cover Image
市場調查報告書

克隆氏症:主要8市場預測 2016-2026年

Crohn's Disease Forecast in 8 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 349940
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
克隆氏症:主要8市場預測 2016-2026年 Crohn's Disease Forecast in 8 Major Markets 2016-2026
出版日期: 2016年01月18日 內容資訊: 英文 48 Pages
簡介

已知為侷限性腸炎的克隆氏症,是慢性發炎性腸道疾病 (CIBD) 之一。克隆氏症影響消化管的所有部分,不過,最常影響腸阻塞及結腸。還有克隆氏症被認為是自體免疫疾病。

本報告提供主要8市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本) 的克隆氏症的目前患者數 (性別、各年齡世代) 調查分析、目前盛行率,加上疾病概要、危險因素、疾病診斷預後、主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

克隆氏症的盛行率top line

克隆氏症患者的特徵

  • 克隆氏症的性狀
  • 克隆氏症的位置、情形
  • 瘻管的存在

克隆氏症相關症狀

  • 胃炎
  • 眼相關症狀
  • 細胞、蛋白質相關症狀
  • 皮膚疾病

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文件

附錄

目錄
Product Code: CROH0010116

image1

Crohn's disease, also known as regional enteritis, is a type of chronic inflammatory bowel disease. While it may affect any part of the gastrointestinal tract, it most commonly affects the ileus and colon. It is thought to be an auto-immune disease, although this theory has been challenged in recent years.

This report provides the current prevalent population for Crohn's disease across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Crohn's have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Crohn's disease include:

  • Gastritis and duodenitis
  • Anaemia
  • Other autoimmune diseases
  • Deep vein thrombosis
  • Skin problems; ulcers, blisters, swelling
  • Inflammation of joints

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Crohn's disease's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Crohn's disease and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Crohn's disease's prevalent population.
  • Identify sub-populations within Crohn's disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Crohn's disease patients.

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Crohn's Disease

Features of Crohn's Disease Patients

  • Behaviour of Crohn's Disease
  • Location and Status of Crohn's disease
  • Presence of Fistulae

Associated Conditions of Crohn's Disease

  • Gastritis
  • Ocular Associated Symptoms
  • Associated Cell and Protein Conditions
  • Dermatological Conditions

Abbreviations and Acronyms used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • 1.Prevalence of Crohn's disease, total (000s)
  • 2.Prevalence of Crohn's disease, males (000s)
  • 3.Prevalence of Crohn's disease, females (000s)
  • 4.Behaviour of Crohn's Disease in patients, total (000s)
  • 5.Location of Crohn's Disease in patients, total (000s)
  • 6.Clinical status of ileus Crohn's Disease patients, total (000s)
  • 7.Clinical status of ileocolonic Crohn's Disease patients, total (000s)
  • 8.Clinical status of colonic Crohn's Disease patients, total (000s)
  • 9.Fistulae in ileus Crohn's Disease in patients, total (000s)
  • 10.Fistulae in ileocolonic Crohn's Disease in patients, total (000s)
  • 11.Fistulae in colonic Crohn's Disease in patients, total (000s)
  • 12.Type of gastritis of Crohn's Disease in patients, total (000s)
  • 13.Prevalence of eye symptoms in Crohn's Disease patients, total (000s)
  • 14.Reported eye conditions in Crohn's Disease patients, total (000s)
  • 15.Elevated CRP (> 10 mg/L) in Crohn's Disease patients, total (000s)
  • 16.Elevated ESR (> 20 mm/hr) in Crohn's Disease patients, total (000s)
  • 17.Anaemia (Hct <36%) in Crohn's Disease patients, total (000s)
  • 18.Macrocytosis (MCV > 98fL) in Crohn's Disease patients, total (000s)
  • 19.Dysplasia in Crohn's Disease patients, total (000s)
  • 20.Oral ulcers in Crohn's Disease patients, total (000s)
  • 21.Erythema nodosum in Crohn's Disease patients, total (000s)
  • 22.Abbreviations and acronyms used in the report
  • 23.USA Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 24.USA Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 25.France Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 26.France Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 27.Germany Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 28.Germany Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 29.Italy Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 30.Italy Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 31.Spain Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 32.Spain Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 33.United Kingdom Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 34.United Kingdom Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 35.Brazil Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 36.Brazil Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
  • 37.Japan Prevalence of Crohn's disease by 5-yr age cohort, males (000s)
  • 38.Japan Prevalence of Crohn's disease by 5-yr age cohort, females (000s)
Back to Top